We showed in the PCCL3 cell lines that the MAPK pathway drives the expression of DUSP5 and DUSP6. We hypothesized that DUSP5 and DUSP6 mRNA levels might be a marker for MAPK pathway activation, with differences according to the genetic alteration present in the carcinoma. Here, DUSP6 is linked to carcinoma.